{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:08:33Z","timestamp":1791565713605,"version":"4.3.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03063-y","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T07:28:00Z","timestamp":1759217280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exosomal transfer of miR-223-3p from carcinoma-associated fibroblasts promotes the malignant properties and chemoresistance of colon cancer cells by targeting NF2\/Hippo signaling"],"prefix":"10.1007","volume":"42","author":[{"given":"Jiaqi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likun","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"3063_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133160","author":"X Wang","year":"2021","unstructured":"Wang X, Wang X, Xu M, Sheng W. Effects of CAF-derived microRNA on tumor biology and clinical applications. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13133160.","journal-title":"Cancers"},{"issue":"3","key":"3063_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3063_CR3","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"3063_CR4","first-page":"220","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220\u201341.","journal-title":"CA Cancer J Clin"},{"issue":"9927","key":"3063_CR5","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/S0140-6736(13)61649-9","volume":"383","author":"H Brenner","year":"2014","unstructured":"Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490\u2013502.","journal-title":"Lancet"},{"key":"3063_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: Past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"key":"3063_CR7","doi-asserted-by":"crossref","unstructured":"Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet 1995, 345(8955):939\u2013944.","DOI":"10.1016\/S0140-6736(95)90696-7"},{"issue":"11","key":"3063_CR8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S1470-2045(12)70424-2","volume":"13","author":"G Ku","year":"2012","unstructured":"Ku G, Tan IB, Yau T, Boku N, Laohavinij S, Cheng AL, et al. Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit. The Lancet Oncol. 2012;13(11):470\u201381.","journal-title":"The Lancet Oncol"},{"issue":"8","key":"3063_CR9","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1200\/JCO.22.00046","volume":"41","author":"D Morton","year":"2023","unstructured":"Morton D, Seymour M, Magill L, Handley K, Glasbey J, Glimelius B, et al. Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial. J Clin Oncol. 2023;41(8):1541\u201352.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3063_CR10","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J, Sun H, Zhang Y, Wang Z, Xun Z, Li Z, et al. Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer. Nat Commun. 2022;13(1):1742.","journal-title":"Nat Commun"},{"issue":"1","key":"3063_CR11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12943-024-02180-y","volume":"23","author":"X Zhou","year":"2024","unstructured":"Zhou X, Han J, Zuo A, Ba Y, Liu S, Xu H, et al. THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K\/AKT activation in colorectal cancer. Mol Cancer. 2024;23(1):282.","journal-title":"Mol Cancer"},{"key":"3063_CR12","first-page":"32","volume":"7","author":"S Tokhanbigli","year":"2024","unstructured":"Tokhanbigli S, Haghi M, Dua K, Oliver BGG. Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer. Cancer Drug Resist. 2024;7:32.","journal-title":"Cancer Drug Resist"},{"issue":"5","key":"3063_CR13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s12094-021-02734-2","volume":"24","author":"S Kamali Zonouzi","year":"2022","unstructured":"Kamali Zonouzi S, Pezeshki PS, Razi S, Rezaei N. Cancer-associated fibroblasts in colorectal cancer. Clin Transl Oncol. 2022;24(5):757\u201369.","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"3063_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u201386.","journal-title":"Nat Rev Cancer"},{"issue":"7973","key":"3063_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-023-06372-2","volume":"620","author":"J Lengrand","year":"2023","unstructured":"Lengrand J, Pastushenko I, Vanuytven S, Song Y, Venet D, Sarate RM, et al. Pharmacological targeting of netrin-1 inhibits EMT in cancer. Nature. 2023;620(7973):402\u20138.","journal-title":"Nature"},{"issue":"14","key":"3063_CR16","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1158\/0008-5472.CAN-18-2952","volume":"79","author":"PJ Sung","year":"2019","unstructured":"Sung PJ, Rama N, Imbach J, Fiore S, Ducarouge B, Neves D, et al. Cancer-associated fibroblasts produce Netrin-1 to control cancer cell plasticity. Cancer Res. 2019;79(14):3651\u201361.","journal-title":"Cancer Res"},{"issue":"21","key":"3063_CR17","doi-asserted-by":"publisher","first-page":"5407","DOI":"10.1158\/1078-0432.CCR-18-0125","volume":"24","author":"H Cho","year":"2018","unstructured":"Cho H, Seo Y, Loke KM, Kim SW, Oh SM, Kim JH, et al. Cancer-stimulated CAFs enhance monocyte differentiation and protumoral TAM activation via IL6 and GM-CSF secretion. Clin Cancer Res. 2018;24(21):5407\u201321.","journal-title":"Clin Cancer Res"},{"key":"3063_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020. https:\/\/doi.org\/10.1126\/science.aau6977.","journal-title":"Science"},{"issue":"1","key":"3063_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-017-0718-4","volume":"16","author":"F Yang","year":"2017","unstructured":"Yang F, Ning Z, Ma L, Liu W, Shao C, Shu Y, et al. Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts. Mol Cancer. 2017;16(1):148.","journal-title":"Mol Cancer"},{"issue":"1","key":"3063_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12943-019-1019-x","volume":"18","author":"JL Hu","year":"2019","unstructured":"Hu JL, Wang W, Lan XL, Zeng ZC, Liang YS, Yan YR, et al. CAfs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Mol Cancer. 2019;18(1):91.","journal-title":"Mol Cancer"},{"issue":"12","key":"3063_CR21","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.18632\/aging.101355","volume":"9","author":"R Bhome","year":"2017","unstructured":"Bhome R, Goh RW, Bullock MD, Pillar N, Thirdborough SM, Mellone M, et al. Exosomal micrornas derived from colorectal cancer-associated fibroblasts: role in driving cancer progression. Aging (Albany NY). 2017;9(12):2666\u201394.","journal-title":"Aging (Albany NY)"},{"key":"3063_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19040988","author":"T Sato","year":"2018","unstructured":"Sato T, Sekido Y. NF2\/Merlin inactivation and potential therapeutic targets in mesothelioma. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19040988.","journal-title":"Int J Mol Sci"},{"key":"3063_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17010064","author":"SH Nouri","year":"2024","unstructured":"Nouri SH, Nitturi V, Ledbetter E, English CW, Lau S, Klisch TJ, et al. Role of NF2 mutation in the development of eleven different cancers. Cancers. 2024. https:\/\/doi.org\/10.3390\/cancers17010064.","journal-title":"Cancers"},{"issue":"1","key":"3063_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ncb1339","volume":"8","author":"F Hamaratoglu","year":"2006","unstructured":"Hamaratoglu F, Willecke M, Kango-Singh M, Nolo R, Hyun E, Tao C, et al. The tumour-suppressor genes NF2\/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nat Cell Biol. 2006;8(1):27\u201336.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"3063_CR25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/onc.2015.125","volume":"35","author":"AM Petrilli","year":"2016","unstructured":"Petrilli AM, Fernandez-Valle C. Role of Merlin\/NF2 inactivation in tumor biology. Oncogene. 2016;35(5):537\u201348.","journal-title":"Oncogene"},{"issue":"8","key":"3063_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043295","volume":"7","author":"LB Murray","year":"2012","unstructured":"Murray LB, Lau YK, Yu Q. Merlin is a negative regulator of human melanoma growth. PLoS ONE. 2012;7(8):e43295.","journal-title":"PLoS ONE"},{"issue":"29","key":"3063_CR27","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1038\/onc.2011.515","volume":"31","author":"Y Shrestha","year":"2012","unstructured":"Shrestha Y, Schafer EJ, Boehm JS, Thomas SR, He F, Du J, et al. PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Oncogene. 2012;31(29):3397\u2013408.","journal-title":"Oncogene"},{"issue":"8","key":"3063_CR28","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S1470-2045(25)00239-6","volume":"26","author":"J Li","year":"2025","unstructured":"Li J, Pan Y, Guo F, Wang C, Liang L, Li P, et al. Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study. Lancet Oncol. 2025;26(8):1055\u201366.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3063_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s13402-013-0164-2","volume":"37","author":"T Cacev","year":"2014","unstructured":"Cacev T, Aralica G, Loncar B, Kapitanovic S. Loss of NF2\/Merlin expression in advanced sporadic colorectal cancer. Cell Oncol (Dordr). 2014;37(1):69\u201377.","journal-title":"Cell Oncol (Dordr)"},{"key":"3063_CR30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12967-016-0811-2","volume":"14","author":"F Felicetti","year":"2016","unstructured":"Felicetti F, De Feo A, Coscia C, Puglisi R, Pedini F, Pasquini L, et al. Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma. J Transl Med. 2016;14:56.","journal-title":"J Transl Med"},{"issue":"92","key":"3063_CR31","first-page":"e51998","volume":"92","author":"S Borowicz","year":"2014","unstructured":"Borowicz S, Van Scoyk M, Avasarala S, Karuppusamy Rathinam MK, Tauler J, Bikkavilli RK, et al. The soft agar colony formation assay. J Vis Exp\u202f: JoVE. 2014;92(92):e51998.","journal-title":"J Vis Exp : JoVE"},{"issue":"1","key":"3063_CR32","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41419-025-07588-y","volume":"16","author":"EG Sun","year":"2025","unstructured":"Sun EG, Choi JN, Park MR, Kim DH, Sung M, Shim HJ, et al. Fgfr4 promotes CAF activation through the CXCL10-CXCR3 axis in colon cancer. Cell Death Dis. 2025;16(1):424.","journal-title":"Cell Death Dis"},{"issue":"5858","key":"3063_CR33","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318(5858):1917\u201320.","journal-title":"Science"},{"issue":"7","key":"3063_CR34","first-page":"4516","volume":"11","author":"B Chai","year":"2019","unstructured":"Chai B, Guo Y, Cui X, Liu J, Suo Y, Dou Z, et al. Mir-223-3p promotes the proliferation, invasion and migration of colon cancer cells by negative regulating PRDM1. Am J Transl Res. 2019;11(7):4516\u201323.","journal-title":"Am J Transl Res"},{"issue":"7","key":"3063_CR35","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1002\/cam4.2850","volume":"9","author":"H Wu","year":"2020","unstructured":"Wu H, Dai Y, Zhang D, Zhang X, He Z, Xie X, et al. LINC00961 inhibits the migration and invasion of colon cancer cells by sponging miR-223-3p and targeting SOX11. Cancer Med. 2020;9(7):2514\u201323.","journal-title":"Cancer Med"},{"issue":"1","key":"3063_CR36","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s13046-023-02921-9","volume":"42","author":"H Bao","year":"2023","unstructured":"Bao H, Peng Z, Cheng X, Jian C, Li X, Shi Y, et al. GABA induced by sleep deprivation promotes the proliferation and migration of colon tumors through miR-223-3p endogenous pathway and exosome pathway. J Exp Clin Cancer Res\u202f: CR. 2023;42(1):344.","journal-title":"J Exp Clin Cancer Res : CR"},{"issue":"5","key":"3063_CR37","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2174\/0929867328666210804090224","volume":"29","author":"MS Khatun","year":"2022","unstructured":"Khatun MS, Alam MA, Shoombuatong W, Mollah MNH, Kurata H, Hasan MM. Recent development of bioinformatics tools for microRNA target prediction. Curr Med Chem. 2022;29(5):865\u201380.","journal-title":"Curr Med Chem"},{"issue":"1","key":"3063_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.devcel.2010.06.015","volume":"19","author":"N Zhang","year":"2010","unstructured":"Zhang N, Bai H, David KK, Dong J, Zheng Y, Cai J, et al. The merlin\/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell. 2010;19(1):27\u201338.","journal-title":"Dev Cell"},{"issue":"21","key":"3063_CR39","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1158\/1078-0432.CCR-14-3096","volume":"21","author":"S Torres","year":"2015","unstructured":"Torres S, Garcia-Palmero I, Herrera M, Bartolome RA, Pena C, Fernandez-Acenero MJ, et al. LOXL2 is highly expressed in cancer-associated fibroblasts and associates to poor colon cancer survival. Clin Cancer Res. 2015;21(21):4892\u2013902.","journal-title":"Clin Cancer Res"},{"issue":"24","key":"3063_CR40","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1158\/0008-5472.CAN-20-0263","volume":"80","author":"MH Mosa","year":"2020","unstructured":"Mosa MH, Michels BE, Menche C, Nicolas AM, Darvishi T, Greten FR, et al. A wnt-induced phenotypic switch in cancer-associated fibroblasts inhibits EMT in colorectal cancer. Cancer Res. 2020;80(24):5569\u201382.","journal-title":"Cancer Res"},{"issue":"10","key":"3063_CR41","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/carcin\/bgw085","volume":"37","author":"Y Hayashi","year":"2016","unstructured":"Hayashi Y, Tsujii M, Kodama T, Akasaka T, Kondo J, Hikita H, et al. P53 functional deficiency in human colon cancer cells promotes fibroblast-mediated angiogenesis and tumor growth. Carcinogenesis. 2016;37(10):972\u201384.","journal-title":"Carcinogenesis"},{"key":"3063_CR42","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3389\/fonc.2020.01747","volume":"10","author":"T Yang","year":"2020","unstructured":"Yang T, Zhiheng H, Zhanhuai W, Qian X, Yue L, Xiaoxu G, et al. Increased RAB31 expression in cancer-associated fibroblasts promotes colon cancer progression through HGF-MET signaling. Front Oncol. 2020;10:1747.","journal-title":"Front Oncol"},{"issue":"6","key":"3063_CR43","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/ijc.32608","volume":"146","author":"X Deng","year":"2020","unstructured":"Deng X, Ruan H, Zhang X, Xu X, Zhu Y, Peng H, et al. Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells. Int J Cancer. 2020;146(6):1700\u201316.","journal-title":"Int J Cancer"},{"issue":"2","key":"3063_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.111956","volume":"391","author":"L Liu","year":"2020","unstructured":"Liu L, Zhang Z, Zhou L, Hu L, Yin C, Qing D, et al. Cancer associated fibroblasts-derived exosomes contribute to radioresistance through promoting colorectal cancer stem cells phenotype. Exp Cell Res. 2020;391(2):111956.","journal-title":"Exp Cell Res"},{"issue":"1","key":"3063_CR45","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12943-021-01463-y","volume":"20","author":"C Li","year":"2021","unstructured":"Li C, Teixeira AF, Zhu HJ, Ten Dijke P. Cancer associated-fibroblast-derived exosomes in cancer progression. Mol Cancer. 2021;20(1):154.","journal-title":"Mol Cancer"},{"key":"3063_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.canlet.2020.07.023","volume":"491","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang S, Lai Q, Fang Y, Wu C, Liu Y, et al. Cancer-associated fibroblasts-derived exosomal miR-17-5p promotes colorectal cancer aggressive phenotype by initiating a RUNX3\/MYC\/TGF-beta1 positive feedback loop. Cancer Lett. 2020;491:22\u201335.","journal-title":"Cancer Lett"},{"key":"3063_CR47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.omtn.2020.11.003","volume":"24","author":"X Chen","year":"2021","unstructured":"Chen X, Liu Y, Zhang Q, Liu B, Cheng Y, Zhang Y, et al. Exosomal miR-590-3p derived from cancer-associated fibroblasts confers radioresistance in colorectal cancer. Mol Ther Nucleic Acids. 2021;24:113\u201326.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"3063_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13046-019-1507-2","volume":"39","author":"X Chen","year":"2020","unstructured":"Chen X, Liu J, Zhang Q, Liu B, Cheng Y, Zhang Y, et al. Exosome-mediated transfer of miR-93-5p from cancer-associated fibroblasts confer radioresistance in colorectal cancer cells by downregulating FOXA1 and upregulating TGFB3. J Exp Clin Cancer Res\u202f: CR. 2020;39(1):65.","journal-title":"J Exp Clin Cancer Res : CR"},{"issue":"9","key":"3063_CR49","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/CM9.0000000000003587","volume":"138","author":"Z Li","year":"2025","unstructured":"Li Z, Zhang T, Yang X, Peng Y. Role of noncoding RNA and protein interaction in pancreatic cancer. Chin Med J. 2025;138(9):1019\u201336.","journal-title":"Chin Med J"},{"issue":"3\u20134","key":"3063_CR50","first-page":"CBM240119","volume":"41","author":"AM Rasteh","year":"2024","unstructured":"Rasteh AM, Liu H, Wang P. Pan-cancer genetic profiles of mitotic DNA integrity checkpoint protein kinases. Cancer Biomark\u202f: Sect A Dis Mark. 2024;41(3\u20134):CBM240119.","journal-title":"Cancer Biomark : Sect A Dis Mark"},{"key":"3063_CR51","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cancergen.2023.10.001","volume":"278\u2013279","author":"H Liu","year":"2023","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet. 2023;278\u2013279:91\u2013103.","journal-title":"Cancer Genet"},{"key":"3063_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.952290","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set. Front Oncol. 2022;12:952290.","journal-title":"Front Oncol"},{"issue":"8","key":"3063_CR53","first-page":"4074","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H. Pan-cancer profiles of the cuproptosis gene set. Am J Cancer Res. 2022;12(8):4074\u201381.","journal-title":"Am J Cancer Res"},{"key":"3063_CR54","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cancergen.2024.05.001","volume":"284\u2013285","author":"J Liu","year":"2024","unstructured":"Liu J, Zhang Y, Wu J, Liu X, Li L, Zhang J. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p\/PLOD1\/Akt\/mTOR pathway. Cancer Genet. 2024;284\u2013285:48\u201357.","journal-title":"Cancer Genet"},{"key":"3063_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cancergen.2024.05.002","volume":"286\u2013287","author":"D Liu","year":"2024","unstructured":"Liu D, Shen M, Liu Z, Chen D, Pan Y, Zhang L, et al. SP1-induced circ_0017552 modulates colon cancer cell proliferation and apoptosis via up-regulation of NET1. Cancer Genet. 2024;286\u2013287:1\u201310.","journal-title":"Cancer Genet"},{"issue":"50","key":"3063_CR56","doi-asserted-by":"publisher","first-page":"87837","DOI":"10.18632\/oncotarget.21237","volume":"8","author":"H Jacob","year":"2017","unstructured":"Jacob H, Stanisavljevic L, Storli KE, Hestetun KE, Dahl O, Myklebust MP. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer. Oncotarget. 2017;8(50):87837\u201347.","journal-title":"Oncotarget"},{"issue":"4","key":"3063_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092921","volume":"9","author":"H Ogata-Kawata","year":"2014","unstructured":"Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K, et al. Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS ONE. 2014;9(4):e92921.","journal-title":"PLoS ONE"},{"issue":"10","key":"3063_CR58","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1038\/bjc.2014.489","volume":"111","author":"G Zheng","year":"2014","unstructured":"Zheng G, Du L, Yang X, Zhang X, Wang L, Yang Y, et al. Serum microrna panel as biomarkers for early diagnosis of colorectal adenocarcinoma. Br J Cancer. 2014;111(10):1985\u201392.","journal-title":"Br J Cancer"},{"issue":"2","key":"3063_CR59","doi-asserted-by":"publisher","first-page":"615","DOI":"10.18632\/aging.101763","volume":"11","author":"W Xiao","year":"2019","unstructured":"Xiao W, Wang X, Wang T, Xing J. MiR-223-3p promotes cell proliferation and metastasis by downregulating SLC4A4 in clear cell renal cell carcinoma. Aging (Albany NY). 2019;11(2):615\u201333.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"3063_CR60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41419-017-0020-9","volume":"9","author":"F Yang","year":"2018","unstructured":"Yang F, Xu Y, Liu C, Ma C, Zou S, Xu X, et al. NF-kappaB\/miR-223-3p\/ARID1A axis is involved in Helicobacter pylori CagA-induced gastric carcinogenesis and progression. Cell Death Dis. 2018;9(1):12.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3063_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15212\/bioi-2024-0012","volume":"5","author":"Z Guo","year":"2024","unstructured":"Guo Z, Saw PE, Jon S. Non-invasive physical stimulation to modulate the tumor microenvironment: unveiling a new frontier in cancer therapy. BIO Integr. 2024;5(1):1\u201314.","journal-title":"BIO Integr"},{"issue":"4","key":"3063_CR62","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/hmg\/3.4.565","volume":"3","author":"H Arakawa","year":"1994","unstructured":"Arakawa H, Hayashi N, Nagase H, Ogawa M, Nakamura Y. Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum Mol Genet. 1994;3(4):565\u20138.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"3063_CR63","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/0165-4608(95)00059-3","volume":"84","author":"AK Rustgi","year":"1995","unstructured":"Rustgi AK, Xu L, Pinney D, Sterner C, Beauchamp R, Schmidt S, et al. Neurofibromatosis 2 gene in human colorectal cancer. Cancer Genet Cytogenet. 1995;84(1):24\u20136.","journal-title":"Cancer Genet Cytogenet"},{"key":"3063_CR64","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2741\/4817","volume":"25","author":"X Wu","year":"2020","unstructured":"Wu X, Mao F, Li N, Li W, Luo Y, Shi W, et al. NF2\/Merlin suppresses proliferation and induces apoptosis in colorectal cancer cells. Front Biosci (Landmark Ed). 2020;25:513\u201325.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"4","key":"3063_CR65","first-page":"2103","volume":"41","author":"KMM Alcantara","year":"2019","unstructured":"Alcantara KMM, Garcia RL. Microrna92a promotes cell proliferation, migration and survival by directly targeting the tumor suppressor gene NF2 in colorectal and lung cancer cells. Oncol Rep. 2019;41(4):2103\u201316.","journal-title":"Oncol Rep"},{"issue":"16","key":"3063_CR66","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1016\/j.febslet.2014.04.001","volume":"588","author":"J Cooper","year":"2014","unstructured":"Cooper J, Giancotti FG. Molecular insights into NF2\/Merlin tumor suppressor function. FEBS Lett. 2014;588(16):2743\u201352.","journal-title":"FEBS Lett"},{"key":"3063_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/cells13070564","author":"R Kumar","year":"2024","unstructured":"Kumar R, Hong W. Hippo signaling at the hallmarks of cancer and drug resistance. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13070564.","journal-title":"Cells"},{"issue":"10","key":"3063_CR68","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.molcel.2022.03.027","volume":"82","author":"S Qi","year":"1857","unstructured":"Qi S, Zhu Y, Liu X, Li P, Wang Y, Zeng Y, et al. 2022 WWC proteins mediate LATS1\/2 activation by Hippo kinases and imply a tumor suppression strategy. Mol cell. 1857;82(10):1850\u201364.","journal-title":"Mol cell"},{"issue":"6","key":"3063_CR69","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nrgastro.2016.59","volume":"13","author":"AW Hong","year":"2016","unstructured":"Hong AW, Meng Z, Guan KL. The hippo pathway in intestinal regeneration and disease. Nat Rev Gastroenterol Hepatol. 2016;13(6):324\u201337.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7575","key":"3063_CR70","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nature15382","volume":"526","author":"A Gregorieff","year":"2015","unstructured":"Gregorieff A, Liu Y, Inanlou MR, Khomchuk Y, Wrana JL. Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer. Nature. 2015;526(7575):715\u20138.","journal-title":"Nature"},{"issue":"4","key":"3063_CR71","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.stem.2020.07.003","volume":"27","author":"P Cheung","year":"2020","unstructured":"Cheung P, Xiol J, Dill MT, Yuan WC, Panero R, Roper J, et al. Regenerative reprogramming of the intestinal stem cell state via hippo signaling suppresses metastatic colorectal cancer. Cell Stem Cell. 2020;27(4):590\u2013604.","journal-title":"Cell Stem Cell"},{"issue":"10","key":"3063_CR72","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100294RR","volume":"35","author":"B Li","year":"2021","unstructured":"Li B, Cao Y, Sun M, Feng H. Expression, regulation, and function of exosome-derived miRNAs in cancer progression and therapy. FASEB J. 2021;35(10):e21916.","journal-title":"FASEB J"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03063-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03063-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03063-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:03:36Z","timestamp":1762427016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03063-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":72,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["3063"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03063-y","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The animal studies were followed with the ethical standards of the ethics committee in Shanxi Province Cancer Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"503"}}